2012
DOI: 10.1155/2012/734834
|View full text |Cite
|
Sign up to set email alerts
|

Placenta Percreta at 17 Weeks with Consecutive Hysterectomy: A Case Report and Review of the Literature

Abstract: Placenta percreta in early pregnancy is an extremely rare but life-threatening complication, for which very few cases have been reported in the literature worldwide, none from the United States. We report a patient with two previous cesarean deliveries, who presented with incomplete abortion at 17 weeks and underwent dilatation and curettage. She was found to have retained, adherent placenta that led to extensive hemorrhage, requiring emergency supracervical hysterectomy. Postoperative course was also complica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 11 publications
0
8
0
1
Order By: Relevance
“…Conservative treatments for placenta percreta remote from delivery have been described, including uterine curettage with packing, primary closure, methotrexate, and uterine vessel occlusion [14,15]. However, there is a four-fold increase in mortality with uterine-sparing treatment compared with hysterectomy [16], with unknown outcomes and potential risks for future pregnancies, and patients often require subsequent hysterectomy for uncontrolled hemorrhage, coagulopathy, or sepsis [18,19,[27], [28], [29], [30]]. Therefore, informed shared-decision making is critical and this patient was counseled on several occasions about management options, including fertility-sparing treatments given her young age and low parity.…”
Section: Discussionmentioning
confidence: 99%
“…Conservative treatments for placenta percreta remote from delivery have been described, including uterine curettage with packing, primary closure, methotrexate, and uterine vessel occlusion [14,15]. However, there is a four-fold increase in mortality with uterine-sparing treatment compared with hysterectomy [16], with unknown outcomes and potential risks for future pregnancies, and patients often require subsequent hysterectomy for uncontrolled hemorrhage, coagulopathy, or sepsis [18,19,[27], [28], [29], [30]]. Therefore, informed shared-decision making is critical and this patient was counseled on several occasions about management options, including fertility-sparing treatments given her young age and low parity.…”
Section: Discussionmentioning
confidence: 99%
“…El manejo universalmente aceptado y considerado como método estándar para el tratamiento del acretismo placentario es la histerectomía (3,12,13) . Un estudio realizado en una institución peruana sobre histerectomía puerperal (14) evidenció que la mayoría de estas (37,5%) se debió a acretismo placentario.…”
Section: Discussionunclassified
“…The most important risk factor is the observation of placenta previa (low lying placenta) after a cesarean delivery. Maternal age of 33 or greater, and multiple cesarean deliveries increase the risk for adherent placenta disorders, therefore a detailed past medical history is essential to determine the overall risk and to anticipate complicated placental implantation disorders [10,16,17,18]. Other risk factors for placenta percreta include, submucous myoma, previous curettage, Asherman's syndrome, advanced maternal age, gandmultiparity, smoking, chronic hypertension as well as a pervious history with adherent placenta disorders [18,19].…”
Section: Diagnosismentioning
confidence: 99%
“…Placenta percreta being the most severe form of all implantation disorders requires aggressive evaluation and management to decrease patient morbidity [16]. Literature suggests that placenta percreta can be diagnosed as early as the 11th week of gestation, however the mode diagnosis of placenta percreta was observed at 35 weeks of gestation.…”
Section: Diagnosismentioning
confidence: 99%